Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$783M |
| 2 |
Danaher
DHR
|
+$423M |
| 3 |
Prologis
PLD
|
+$411M |
| 4 |
Apple
AAPL
|
+$388M |
| 5 |
Amazon
AMZN
|
+$325M |
Top Sells
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$505M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGB
3701
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
| $450K | ﹤0.01% |
1,779
+78
| +5% | +$19.7K |
|
|
DMTK
3702
DELISTED
DermTech, Inc. Common Stock
DMTK
| $450K | ﹤0.01% |
254,424
+3,299
| +1% | +$5.84K |
|
|
PTRS
3703
DELISTED
Partners Bancorp Common Stock
PTRS
| $449K | ﹤0.01% |
50,752
+4,311
| +9% | +$38.1K |
|
|
BCLI
3704
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $448K | ﹤0.01% |
18,247
-195
| -1% | -$4.79K |
|
3705
Cidara Therapeutics
CDTX
$1.6B
| $448K | ﹤0.01% |
29,636
+387
| +1% | +$5.85K |
|
3706
Galapagos
GLPG
$2.15B
| $448K | ﹤0.01% |
10,095
| – | – |
|
3707
Verrica Pharmaceuticals
VRCA
$47.2M
| $448K | ﹤0.01% |
16,296
+1,272
| +8% | +$35K |
|
|
INFI
3708
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $448K | ﹤0.01% |
807,517
-62,058
| -7% | -$34.4K |
|
3709
Adverum Biotechnologies
ADVM
$72.8M
| $447K | ﹤0.01% |
77,215
+1,656
| +2% | +$9.59K |
|
3710
Curis
CRIS
$22.6M
| $447K | ﹤0.01% |
40,663
+771
| +2% | +$8.48K |
|
3711
Spero Therapeutics
SPRO
$111M
| $445K | ﹤0.01% |
257,284
-32,974
| -11% | -$57K |
|
|
AUD
3712
DELISTED
Audacy, Inc.
AUD
| $445K | ﹤0.01% |
1,978,184
-69,254
| -3% | -$15.6K |
|
3713
Fortress Biotech
FBIO
$107M
| $444K | ﹤0.01% |
45,215
-102
| -0.2% | -$1K |
|
3714
Knightscope
KSCP
$57.6M
| $443K | ﹤0.01% |
4,698
-10
| -0.2% | -$943 |
|
|
LOAN
3715
Manhattan Bridge Capital
LOAN
$61.5M
| $443K | ﹤0.01% |
82,222
+645
| +0.8% | +$3.48K |
|
3716
Rekor Systems
REKR
$153M
| $443K | ﹤0.01% |
369,954
+17,652
| +5% | +$21.1K |
|
3717
SELLAS Life Sciences
SLS
$196M
| $443K | ﹤0.01% |
188,066
+43,347
| +30% | +$102K |
|
3718
KB Financial Group
KB
$28.9B
| $440K | ﹤0.01% |
11,388
| – | – |
|
3719
Wrap Technologies
WRAP
$85.9M
| $440K | ﹤0.01% |
260,726
+2,955
| +1% | +$4.99K |
|
|
CWBC
3720
DELISTED
Community West BanCshares
CWBC
| $440K | ﹤0.01% |
29,440
-33
| -0.1% | -$493 |
|
|
GRRR
3721
Gorilla Technology Group
GRRR
$419M
| $438K | ﹤0.01% |
5,410
+24
| +0.4% | +$1.94K |
|
3722
LifeVantage
LFVN
$150M
| $438K | ﹤0.01% |
117,895
+1,214
| +1% | +$4.51K |
|
3723
Biglari Holdings Class A
BH.A
$957M
| $437K | ﹤0.01% |
630
-1
| -0.2% | -$694 |
|
3724
Celestica
CLS
$28.1B
| $436K | ﹤0.01% |
38,740
| – | – |
|
3725
Patria Investments
PAX
$2.24B
| $436K | ﹤0.01% |
31,353
| – | – |
|